MARSHALL MEDICAL CENTER - SOUTH — History
CCN 010005 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$187M
Latest Revenue (FY2022)
+1.9%
Revenue CAGR (3yr)
-6.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $180M | $179M | $187M | +4.5% | +1.9% |
| Operating Expenses | $199M | $178M | $199M | +11.4% | +0.0% |
| Operating Margin | -10.4% | 0.2% | -6.3% | -3034.4% | +0.0% |
| Net Income | $-19M | $0M | $-12M | -3166.6% | +0.0% |
| Licensed Beds | 195 | 192 | 178 | -7.3% | -4.5% |
| Total Patient Days | 35,813 | 37,391 | 35,493 | -5.1% | -0.4% |
| Medicare Day % | 36% | 31% | 26% | -14.7% | -14.4% |
| Medicaid Day % | 20% | 21% | 24% | +14.7% | +9.5% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +3.9% ($180M → $187M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.9%
This Hospital
+7.6%
State Avg
Latest Margin
-6.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $190M | -4.3% |
| FY2024 (proj) | $194M | -2.3% |
| FY2025 (proj) | $197M | -0.2% |